Biotech & Healthtech
Guideline
United-Kingdom
Data Breach
Health Data Strategy
Testimonial
Clinical Trial Sponsor
USA
LLMS
Data Transfers
GDPR
Regulation
Health Data Warehouse
ICF
Clinical Trials
AI
DPIA
EU Privacy Law
US Privacy Law
Trending Articles
Latest Articles & News
UK's NHS says hackers have published data stolen in ransomware attack
The UK's National Health Service (NHS) has confirmed that data stolen in a ransomware attack on Synnovis, a medical diagnostics service, has been published online, and the extent of the breach and its impact on patients is under investigation.
FTC Completes Updates to Health Breach Notification Rule for Health Apps
The Federal Trade Commission announced it has finalized changes to the Health Breach Notification Rule (HBNR) that will strengthen and modernize the rule by clarifying its applicability to health apps and other similar technologies and expanding the information that covered entities must provide to consumers when notifying them of a breach of their health data.
The European Health Data Space overcomes its final obstacle in Parliament
iliomad is deligthed to have supported the ICM - Institut du Cancer de Montpellier in their CNIL's authorization process
We are delighted to share that the ICM - Institut du Cancer de Montpellier was authorized by the French Data Protection Authority (CNIL) to conduct APAD-ECO study. The CNIL granted authorization to conduct a medico-economic study on the effects of physical activity in women treated for breast cancer on April, 19th. This groundbreaking study involves combining data from two clinical trials with that of the Caisse nationale de l’Assurance Maladie, covering the period from 2009 to 2022. The study aims to assess the long-term impacts of physical activity in patients who have undergone treatment for breast cancer. We are proud to have contributed to this project by providing the ICM - Institut du Cancer de Montpellier with a compliant Data Protection Impact Assessment (DPIA), a crucial step in obtaining CNIL approval.